罗氏取得用于抗体免疫测定的冠状核衣壳抗原专利

Core Viewpoint - The National Intellectual Property Administration has granted a patent to Hoffmann-La Roche Ltd for a technology related to "coronavirus nucleocapsid antigen for antibody immunoassays" with the announcement number CN115843334B, filed in April 2021 [1] Group 1 - The patent pertains to a specific application in the field of antibody testing for coronavirus [1] - The patent was officially granted after a filing period that began in April 2021 [1]